DNA Damage and Repair Biomarkers of Immunotherapy Response
Explore this paper's citation graph
Summary
The mechanisms by which DNA damage and genomic instability have been found to shape the anti-tumor immune response are summarized and clinical efforts to use DNA repair biomarkers to guide use of immune-directed therapies are described.
- Type
- article
- Published
- 2017-06-19
- Cited by
- 564
- References
- 187
- OpenAlex
- https://openalex.org/W28630051
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:4500973
Keywords
Computer science
References
- Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation.
- Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.
- Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing Panels.
- The PARP1 inhibitor BMN 673 exhibits immunoregulatory effects in a Brca1(-/-) murine model of ovarian cancer.
- Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- Irradiation of Tumor Cells Up-Regulates Fas and Enhances CTL Lytic Activity and CTL Adoptive Immunotherapy
- Integrated Genomic Characterization of Endometrial Carcinoma
- cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING
- STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells
- Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1.
- Whole–genome characterization of chemoresistant ovarian cancer
- Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients.
- Repair Pathway Choices and Consequences at the Double-Strand Break
- Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
- Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
- Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity
- Adenoma development in familial adenomatous polyposis and MUTYH‐associated polyposis: somatic landscape and driver genes
- Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1
- Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial.
Cited by
- Nuclear localization of PD-L1: artifact or reality?
- Inhibition of ATM increases interferon signaling and sensitizes pancreatic cancer to immune checkpoint blockade therapy
- Homology-Directed Repair and the Role of BRCA1, BRCA2, and Related Proteins in Genome Integrity and Cancer
- Prognostic value of programmed death ligand 1, p53, and Ki-67 in patients with advanced-stage colorectal cancer.
- A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations
- Directing the use of DDR kinase inhibitors in cancer treatment
- Can radiotherapy potentiate the effectiveness of immune checkpoint inhibitors in lung cancer?
- Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non-small Cell Lung Cancer.
- INTEGRATIVE CANCER IMMUNOGENOMIC ANALYSIS OF SERIAL MELANOMA BIOPSIES REVEALS CORRELATES OF RESPONSE AND RESISTANCE TO SEQUENTIAL CTLA-4 AND PD-1 BLOCKADE TREATMENT
- Targeting DNA damage repair in small cell lung cancer and the biomarker landscape.
- Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers.
- From checkpoint to checkpoint: DNA damage ATR/Chk1 checkpoint signalling elicits PD-L1 immune checkpoint activation
- BAP1 Haploinsufficiency Predicts a Distinct Immunogenic Class of Malignant Peritoneal Mesothelioma
- Genotypic and Phenotypic Signatures to Predict Immune Checkpoint Blockade Therapy Response in Colorectal Cancer Patients
- The clinical significance of PD-L1 in advanced gastric cancer is dependent on ARID1A mutations and ATM expression
- A Review of Nanoscale Characterizing Individual DNA Behaviors Using Atomic Force Microscopy
- Therapeutic Strategies against Cyclin E1-Amplified Ovarian Cancers
- Hypothesis: can the abscopal effect explain the impact of adjuvant radiotherapy on breast cancer mortality?
- Applying Precision Oncology Principles in Radiation Oncology.
- Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities
Related papers
No related papers recorded.